A series of stories that looks at the breakthroughs, setbacks, and overall status of vaccines and cures for hard-to-treat ...

Massachusetts families are still struggling to find alternatives almost a year after GlaxoSmithKline canceled a widely ...

With an accuracy of 86%, the biomarker panel has the potential to be clinically useful in diagnosis, management, and ...

The arrest in the slaying of UnitedHealthcare CEO Brian Thompson was the first step to putting his alleged killer behind bars ...

Maud Gatewood (1934–2004) is an essential figure in mid- and late-20th century art in North Carolina, both as an esteemed ...

Goldman Sachs analyst Rajan Sharma maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £16.90.

Graham Parry, an analyst from Bank of America Securities, maintained the Sell rating on GlaxoSmithKline (GSK – Research Report). The associated ...

The project signals growing confidence in Dubai's commercial real estate sector, which has seen strong leasing activity and ...

Mepolizumab, a biologic approved for asthma, is not currently approved for COPD, but data from a 2017 study showed a trend ...

Inequalities in childhood vaccination are widening in England, with uptake rates of five key vaccines consistently lower in young children living in areas of higher deprivation from 2019 to 2023, ...

Objective To quantify changes in inequalities in uptake of childhood vaccination during a period of steadily declining overall childhood vaccination rates in England. Design Longitudinal study.

Tempus AI leverages AI for precision medicine, offering genomics, data services, and AI applications. Click here to read an ...